HuagongsheHuagongshe Chemistry Print Report · For research reference only
HRID 2101347Generated: October 30, 2026
Methylamine → 3-((7-(4-chlorophenyl)-3-oxo-8-(pyridin-4-yl)-[1,2,4]triazolo[4,3-a]pyridin-2(3H)-yl)methyl)-N-methyl-6-(trifluoromethyl)picolinamide
https://huagongshe.com/reaction/2101347
Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | Methylamine | HCID 6329 | — |
| Reactant | Triethylamine | HCID 8471 | — |
| Reactant | HCID 57799456 | HCID 57799456 | — |
| Solvent | Tetrahydrofuran | HCID 8028 | — |
| Product | 3-((7-(4-chlorophenyl)-3-oxo-8-(pyridin-4-yl)-[1,2,4]triazolo[4,3-a]pyridin-2(3H)-yl)methyl)-N-methyl-6-(trifluoromethyl)picolinamide | HCID 57799413 | — |
Reaction Steps
To a stirring solution of 3-((7-(4-chlorophenyl)-3-oxo-8-(pyridin-4-yl)-[1,2,4]triazolo[4,3-a]pyridin-2(3H)-yl)methyl)-6-(trifluoromethyl)picolinoyl chloride (36 mg, 0.066 mmol) in anhydrous THF (1 mL) at 0° C. was added 2 M methylamine solution in THF (0.33 mL, 0.66 mmol), followed by Et3N (0.046 mL, 0.33 mmol). The resulting mixture was stirred at 0° C. for 30 min, then at room temperature for 16 h. Analysis by HPLC/MS indicated the starting acid chloride had been consumed and the desired product had formed. The reaction mixture was diluted with water and extracted with EtOAc (15 mL×2). The combined EtOAc extracts were washed with saturated aqueous NaCl, dried over Na2SO4 and concentrated under reduced pressure. The residue was purified using preparative reverse phase HPLC (Phenomenex Luna 5 μm C-18 21.2×100 mm column eluted with a linear gradient of 50% to 100% B over 8 min (A=0.1% trifluoroacetic acid, 90% water, 10% methanol and B=0.1% trifluoroacetic acid, 90% methanol, 10% water) with flow rate at 20 mL/min and UV detection at 220 nm). The desired fractions were concentrated under reduced pressure. The residue was dissolved in EtOAc, washed with saturated aqueous NaHCO3 once, water twice, then saturated aqueous NaCl, dried over Na2SO4 and evaporated. The residue was dissolved in acetonitrile, frozen and lyophilized to afford 12 mg (34%) of the title compound as a pale yellow powder. HPLC/MS: retention time=2.83 min, [M+H]+=539.2.
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US07572808B2 |
|---|
| Source dataset | uspto-grants-2009_08 |
|---|
| ORD ID | ord-17b275456a1f40968e7492a344fdee7b |
|---|
| Source note | uspto-grants-2009_08 |
|---|